New York 2025-2026 Regular Session

New York Assembly Bill A03775

Introduced
1/30/25  
Refer
1/30/25  

Caption

Relates to medical use of psilocybin; establishes a psilocybin assisted therapy grant program; makes an appropriation therefor.

Companion Bills

NY S00495

Same As Relates to medical use of psilocybin; establishes a psilocybin assisted therapy grant program; makes an appropriation therefor.

Previously Filed As

NY S00495

Relates to medical use of psilocybin; establishes a psilocybin assisted therapy grant program; makes an appropriation therefor.

NY A03845

Establishes the psilocybin assisted therapy pilot program; provides such program will be offered to veterans and first responders from New York state; establishes a psilocybin assisted therapy pilot program fund.

NY SF4485

Psilocybin therapeutic use program establishment

NY SF3971

Psilocybin therapeutic use program establishment

NY HB1809

Establishing a medical psilocybin advisory board to assess the advantages and disadvantages of the use of psilocybin for therapeutic purposes.

NY SB219

Medical Psilocybin Act

NY H4986

Relative to therapeutic psilocybin treatment centers

NY A1526

Establishes Psilocybin Behavioral Health Access and Therapy Pilot Program; appropriates $6 million.

NY HB05456

An Act Allowing The Use Of Psilocybin For Medicinal And Therapeutic Purposes.

NY H2532

Relative to therapeutic psilocybin treatment centers

Similar Bills

NH HB1796

Allowing the use of psilocybin in approved clinical settings to treat qualified medical conditions.

IA HF978

A bill for an act relating to the production and administration of psilocybin, and providing penalties. (Formerly HF 620.)

IA HF620

A bill for an act relating to the production of psilocybin and the administration of psilocybin to persons with post-traumatic stress disorder, and providing penalties.(See HF 978.)

IA HF2085

A bill for an act relating to the production and administration of psilocybin and providing penalties.

NJ S3148

"Psilocybin Behavioral Health Access and Services Act"; authorizes production and use of psilocybin to promote health and wellness.

NH HB1809

Establishing a medical psilocybin advisory board to assess the advantages and disadvantages of the use of psilocybin for therapeutic purposes.

NM SB219

Medical Psilocybin Act

MA H4050

To amend the General Laws, in relation to promoting the health and well-being of the residents of the Commonwealth of Massachusetts by establishing a comprehensive framework supporting public health and safety through regulated adult use, support services, and cultivation of psilocybin-containing fungi; and providing for taxation and appropriation thereof